The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Anticoagulation of Pregnant Women With Mechanical Heart Valves: A Systematic Review of the Literature
Abstract
BACKGROUND: The management of women with prosthetic heart valves during pregnancy poses a particular challenge as there are no available controlled clinical trials to provide guidelines for effective antithrombotic therapy. Oral anticoagulants such as warfarin sodium cause fetal embryopathy; subcutaneous administration of heparin sodium has been reported to be ineffective in preventing thromboembolic complications. OBJECTIVE: To identify the risks of maternal and fetal complications in women with mechanical heart valves treated with different anticoagulation regimens during pregnancy. METHODS: We performed a systematic review of the literature to determine pooled estimates of maternal and fetal risks associated with the 3 commonly used approaches: (1) oral anticoagulants (OA) throughout pregnancy, (2) replacing OA with heparin in the first trimester (from 6-12 weeks' gestation), and (3) heparin use throughout pregnancy. Fetal outcomes included spontaneous abortions and fetopathic effects, and maternal outcomes were major bleeding, thromboembolic complications, and death. RESULTS: The use of OA throughout pregnancy is associated with warfarin embryopathy in 6.4% (95% confidence interval [CI], 4.6%-8.9%) of livebirths. The substitution of heparin at or prior to 6 weeks, and continued until 12 weeks, eliminated this risk. Overall risks for fetal wastage (spontaneous abortion, stillbirths, and neonatal deaths) were similar in women treated with OA throughout, compared with women treated with heparin in the first trimester. Maternal mortality was 2.9% (95% CI, 1.9%-4.2%). Maj or bleeding events occurred in 2.5% (95% CI, 1.7%-3.5%) of all pregnancies, most at the time of delivery. The regimen associated with the lowest risk of valve thrombosis (3.9%; 95% CI, 2.9-5.9%) was the use of OA throughout; using heparin only between 6 and 12 weeks' gestation was associated with an increased risk of valve thrombosis (9.2%; 95% CI, 5.9%-13.9%). CONCLUSIONS: Thromboembolic prophylaxis of women with mechanical heart valves during pregnancy is best achieved with OA; however, this increases the risk of fetal embryopathy. Substituting OA with heparin between 6 and 12 weeks reduces the risk of fetopathic effects, but with an increased risk of thromboembolic complications. The use of low-dose heparin is definitely inadequate; the use of adjusted-dose heparin warrants aggressive monitoring and appropriate dose adjustment. Large prospective trials to determine the best regimen for these women are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Maternal and fetal sequelae of anticoagulation during pregnancy
Hall, J. G., Pauli, R. M., & Wilson, K. M. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90181-3 · Cited by 997
Vongpatanasin, W., Hillis, L. D., & Lange, R. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608083350607 · Cited by 811
A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement
Turpie, A., Gent, M., Laupacis, A., Latour, Y., Gunstensen, J., Basile, F., Klimek, M., & Hirsh, J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308193290802 · Cited by 547
Risks of Anticoagulant Therapy in Pregnant Women with Artificial Heart Valves
Iturbe-Alessio, I., Fonseca, M. D. C., Mutchinik, O., Santos, M. A., Zajarías, A., & Salazar, E. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611273152205 · Cited by 307
Outcome of pregnancy in women with valve prostheses.
Sbarouni, E., & Oakley, C. M. (1994) · Heart · doi:10.1136/hrt.71.2.196 · Cited by 305
Nelson-Piercy, C., Letsky, E. A., & de Swiet, M. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70403-4 · Cited by 260
Risks to the Fetus of Anticoagulant Therapy During Pregnancy
Ginsberg, J. S., Hirsh, J., Turner, D. C., Levine, M. N., & Burrows, R. (1989) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646558 · Cited by 218
Self-citationSalazar, E., Izaguirre, R., Verdejo, J., & Mutchinick, O. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00072-1 · Cited by 183
Born, D., Martinez, E. E., de Almeida, P. A. M., Santos, D. V., de Carvalho, A. C. C., Moron, A. F., Miyasaki, C. H., Moraes, S. D., & Ambrose, J. A. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90606-v · Cited by 127
Cited by
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176857 · Cited by 8,495
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
Authors/Task Force Members, Vahanian, A., Baumgartner, H., Bax, J., Butchart, E., Dion, R., Filippatos, G., Flachskampf, F., Hall, R., Iung, B., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl428 · Cited by 3,593
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000031 · Cited by 2,905
2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000029 · Cited by 2,566
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000932 · Cited by 2,449
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomström-Lundqvist, C., Cífková, R., De Bonis, M., Iung, B., Johnson, M. R., Kintscher, U., Kranke, P., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy340 · Cited by 2,292
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.007 · Cited by 2,257
Warnes, C. A., Williams, R. G., Bashore, T. M., Child, J. S., Connolly, H. M., Dearani, J. A., del Nido, P., Fasules, J. W., Graham, T. P., Hijazi, Z. M., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.190811 · Cited by 2,066
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.018 · Cited by 1,982
ESC Guidelines on the management of cardiovascular diseases during pregnancy
Endorsed by the European Society of Gynecology (ESG), T. A. F. E. P. C. (., Authors/Task Force Members, Regitz-Zagrosek, V., Blomstrom Lundqvist, C., Borghi, C., Cifkova, R., Ferreira, R., Foidart, J.-M., Gibbs, J. S. R., Gohlke-Baerwolf, C., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr218 · Cited by 1,924
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.05.021 · Cited by 1,702
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O'Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.537 · Cited by 1,642
Stout, K. K., Daniels, C. J., Aboulhosn, J. A., Bozkurt, B., Broberg, C. S., Colman, J. M., Crumb, S. R., Dearani, J. A., Fuller, S., Gurvitz, M., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000603 · Cited by 1,602
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Middeldorp, S., Veenstra, D. L., Prabulos, A.-M., & Vandvik, P. O. (2012) · Chest · doi:10.1378/chest.11-2300 · Cited by 1,525
2006 WRITING COMMITTEE MEMBERS, Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.190748 · Cited by 1,114
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease
Stout, K. K., Daniels, C. J., Aboulhosn, J. A., Bozkurt, B., Broberg, C. S., Colman, J. M., Crumb, S. R., Dearani, J. A., Fuller, S., Gurvitz, M., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.1029 · Cited by 1,080
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.035 · Cited by 1,075
2014 AHA/ACC guideline for the management of patients with valvular heart disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.05.014 · Cited by 989
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary
Stout, K. K., Daniels, C. J., Aboulhosn, J. A., Bozkurt, B., Broberg, C. S., Colman, J. M., Crumb, S. R., Dearani, J. A., Fuller, S., Gurvitz, M., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.1028 · Cited by 879
Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Pabinger, I., Sofaer, S., & Hirsh, J. (2008) · Chest · doi:10.1378/chest.08-0761 · Cited by 793
Ferro, J. M., Bousser, M. ‐., Canhão, P., Coutinho, J. M., Crassard, I., Dentali, F., di Minno, M., Maino, A., Martinelli, I., Masuhr, F., et al. (2017) · European Journal of Neurology · doi:10.1111/ene.13381 · Cited by 749
Bates, S. M., Rajasekhar, A., Middeldorp, S., McLintock, C., Rodger, M. A., James, A. H., Vazquez, S. R., Greer, I. A., Riva, J. J., Bhatt, M., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018024802 · Cited by 625
Guidelines on oral anticoagulation with warfarin – fourth edition
Keeling, D., Baglin, T., Tait, C., Watson, H., Perry, D., Baglin, C., Kitchen, S., Makris, M., & British Committee for Standards in Haematology (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08753.x · Cited by 586
Medical device‐induced thrombosis: what causes it and how can we prevent it?
Jaffer, I. H., Fredenburgh, J. C., Hirsh, J., & Weitz, J. I. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12961 · Cited by 557
Use of Antithrombotic Agents During Pregnancy
Bates, S. M., Greer, I. A., Hirsh, J., & Ginsberg, J. S. (2004) · Chest · doi:10.1378/chest.126.3_suppl.627s · Cited by 552
Self-citationStout, K. K., Daniels, C. J., Aboulhosn, J. A., Bozkurt, B., Broberg, C. S., Colman, J. M., Crumb, S. R., Dearani, J. A., Fuller, S., Gurvitz, M., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000602 · Cited by 533
Canobbio, M. M., Warnes, C. A., Aboulhosn, J., Connolly, H. M., Khanna, A., Koos, B. J., Mital, S., Rose, C., Silversides, C., & Stout, K. (2017) · Circulation · doi:10.1161/cir.0000000000000458 · Cited by 475
Guidance for the treatment and prevention of obstetric-associated venous thromboembolism
Bates, S. M., Middeldorp, S., Rodger, M., James, A. H., & Greer, I. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1309-0 · Cited by 441
High-Risk Cardiac Disease in Pregnancy
Elkayam, U., Goland, S., Pieper, P. G., & Silversides, C. K. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.048 · Cited by 370
Recommendations for the management of patients after heart valve surgery
Butchart, E. G., Gohlke-Bärwolf, C., Antunes, M. J., Tornos, P., De Caterina, R., Cormier, B., Prendergast, B., Iung, B., Bjornstad, H., Leport, C., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi426 · Cited by 358
van Hagen, I. M., Roos-Hesselink, J. W., Ruys, T. P. E., Merz, W. M., Goland, S., Gabriel, H., Lelonek, M., Trojnarska, O., Al Mahmeed, W. A., Balint, H. O., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.015242 · Cited by 356
Venous Thromboembolism and Antithrombotic Therapy in Pregnancy
Chan, W.-S., Rey, E., Kent, N. E., Chan, W.-S., Kent, N. E., Rey, E., Corbett, T., David, M., Douglas, M. J., Gibson, P. S., et al. (2014) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30569-7 · Cited by 315
Self-citationUse of Medication for Cardiovascular Disease During Pregnancy
Halpern, D. G., Weinberg, C. R., Pinnelas, R., Mehta-Lee, S., Economy, K. E., & Valente, A. M. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.075 · Cited by 309
2025 ESC Guidelines for the management of cardiovascular disease and pregnancy
De Backer, J., Haugaa, K. H., Hasselberg, N. E., de Hosson, M., Brida, M., Castelletti, S., Cauldwell, M., Cerbai, E., Crotti, L., de Groot, N. M. S., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf193 · Cited by 307
Venous Thromboembolism in Pregnancy
James, A. H. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.184127 · Cited by 294
Regional anaesthesia in patients on antithrombotic drugs: Joint ESAIC/ESRA guidelines
Kietaibl, S., Ferrandis, R., Godier, A., Llau, J., Lobo, C., Macfarlane, A. J., Schlimp, C. J., Vandermeulen, E., Volk, T., von Heymann, C., et al. (2022) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000001600 · Cited by 289
Ferro, J. M., Bousser, M.-G., Canhão, P., Coutinho, J. M., Crassard, I., Dentali, F., di Minno, M., Maino, A., Martinelli, I., Masuhr, F., et al. (2017) · European Stroke Journal · doi:10.1177/2396987317719364 · Cited by 282
Use of Antithrombotic Agents During Pregnancy
Ginsberg, J. S., Greer, I., & Hirsh, J. (2001) · Chest · doi:10.1378/chest.119.1_suppl.122s · Cited by 280
Self-citationThrombolytic therapy in pregnancy
Leonhardt, G., Gaul, C., Nietsch, H. H., Buerke, M., & Schleussner, E. (2006) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-006-5709-z · Cited by 278
Valvular Heart Disease and Pregnancy
Elkayam, U., & Bitar, F. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.087 · Cited by 275
2020 ACC/AHA guideline for the management of patients with valvular heart disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.04.002 · Cited by 279
Metadata
- Authors
- Chan, W. S., Anand, S., & Ginsberg, J. S.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2000-01-24
- Volume
- 160
- Issue
- 2
- Pages
- 191
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2138444098
- Cited by
- 749
- References
- 34
- FWCI
- 17.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.